Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Epivir-HBV (Lamivudine) Tablets
Company:  Glaxo Wellcome
Application No.:  21-003 & 21-004
Approval Date: 12/8/1998

 

Date created: September 07, 2001

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-